Asya A. Gusina
Asya A. Gusina has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- A. P. Mikhalenka
Institute of Genetics and Cytology of the National Academy of Sciences of Belarus
2 shared publications - A. A. Efimova
State Institution Republican Scientific and Practical Centre «Cardiology
1 shared publication A. V. Kilchevsky
1 shared publication- Alexander V. Kilchevsky
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
1 shared publication - Dmitriy A. Antonenka
Republican Research and Clinical Center of Neurology and Neurosurgery
1 shared publication - E. S. Rebeko
State Institution “Republican Scientific and Practical Centre of Cardiology
1 shared publication
Latest Publications
- 13 October 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 525
Sialidosis Type II in Siblings with a Novel NEU1 Variant: Clinical and Molecular Genetic Analysis
- 13 October 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 525
Sialidosis Type II in Siblings with a Novel NEU1 Variant: Clinical and Molecular Genetic Analysis
- 3 June 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (5) , 131-136
Phenomenon of anticipation in a patient with dystrophic myotonia type 1
The article presents the authors’ clinical observation of a patient with genetically confirmed dystrophic myotonia type 1 and describes the phenomenon of anticipation associated with an increase in the severity of symptoms, an earlier onset of the disease in each subsequent generation, and due to an increasing expansion and the sex of the parent transmitting the mutation. In the described family case, dystrophic myotonia type 1 was observed in four generations. It was inherited through the maternal line as an increase in the number of trinucleotide repeats in the DMPK gene and the severity of clinical symptoms in patients.
- 3 June 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (5) , 131-136
Phenomenon of anticipation in a patient with dystrophic myotonia type 1
The article presents the authors’ clinical observation of a patient with genetically confirmed dystrophic myotonia type 1 and describes the phenomenon of anticipation associated with an increase in the severity of symptoms, an earlier onset of the disease in each subsequent generation, and due to an increasing expansion and the sex of the parent transmitting the mutation. In the described family case, dystrophic myotonia type 1 was observed in four generations. It was inherited through the maternal line as an increase in the number of trinucleotide repeats in the DMPK gene and the severity of clinical symptoms in patients.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CONGENITAL DEFECTS OF THE IMMUNE SYSTEM AS A MANIFESTATION OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN CHILDREN
Background. Currently, monogenic inflammatory bowel disease-like (IBD) pathologies such as congenital immunity defects, genetic epithelial barrier defects and others are becoming increasingly relevant. Objective. To analyze genetic defects associated with IBD-like immunopathology. Material and methods. The study included 46 patients with IBD manifestations aged 18 years or younger, who underwent whole-exome sequencing using the NGS method. All calculations were performed using the R statistical package, version 4.1. Results. There were identified 11 (23,9%) patients with gene mutations indicating congenital defects of the immune system (CDIS). Of these, 3 (27,3%) children were found to have abnormalities in the genes of immune dysregulation - CTLA-4 (c.151C>T (p.Arg 51*)), (FOXP3 (c.851C>T (p.Ala284Val)) and FOXP3 (c.748_750del (p.Lys250del)); 3 (27.3%) patients had abnormalities in the SLC5A1 gene (c.1666-2delA), SLC5A1 gene (c.1666-2delA and c.1680T>G(p.(Cys560Trp)) responsible for the disruption of the barrier function of the epithelium; 2 (18.2%) patients had abnormalities in the PIK3CD gene (c.3061G>A (p.Glu1021Lys)), manifested as CDIS with a predominant deficiency of antibodies; in 2 (18.2%) patients abnormalities in genes affecting cellular and humoral immunity were detected: JAK3 (c.2518C>T(p.Arg840Cys)), CD40LG (c.430G>A (p.Gly144Arg)); and in one case (9,1%) a congenital defect in the number or function of phagocytes – in CFTR gene (c.43delC (p.Leu15fs) and c.1210-11T>G) was established. According to clinical signs, patients with CDIS had only some differences from IBD patients. Conclusion. It is advisable to conduct molecular genetic analysis of target genes in IBD patients with very early onset of gastrointestinal lesions, which allows timely diagnosis of congenital defects of the immune system for subsequent prescription of adequate therapy.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CONGENITAL DEFECTS OF THE IMMUNE SYSTEM AS A MANIFESTATION OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN CHILDREN
Background. Currently, monogenic inflammatory bowel disease-like (IBD) pathologies such as congenital immunity defects, genetic epithelial barrier defects and others are becoming increasingly relevant. Objective. To analyze genetic defects associated with IBD-like immunopathology. Material and methods. The study included 46 patients with IBD manifestations aged 18 years or younger, who underwent whole-exome sequencing using the NGS method. All calculations were performed using the R statistical package, version 4.1. Results. There were identified 11 (23,9%) patients with gene mutations indicating congenital defects of the immune system (CDIS). Of these, 3 (27,3%) children were found to have abnormalities in the genes of immune dysregulation - CTLA-4 (c.151C>T (p.Arg 51*)), (FOXP3 (c.851C>T (p.Ala284Val)) and FOXP3 (c.748_750del (p.Lys250del)); 3 (27.3%) patients had abnormalities in the SLC5A1 gene (c.1666-2delA), SLC5A1 gene (c.1666-2delA and c.1680T>G(p.(Cys560Trp)) responsible for the disruption of the barrier function of the epithelium; 2 (18.2%) patients had abnormalities in the PIK3CD gene (c.3061G>A (p.Glu1021Lys)), manifested as CDIS with a predominant deficiency of antibodies; in 2 (18.2%) patients abnormalities in genes affecting cellular and humoral immunity were detected: JAK3 (c.2518C>T(p.Arg840Cys)), CD40LG (c.430G>A (p.Gly144Arg)); and in one case (9,1%) a congenital defect in the number or function of phagocytes – in CFTR gene (c.43delC (p.Leu15fs) and c.1210-11T>G) was established. According to clinical signs, patients with CDIS had only some differences from IBD patients. Conclusion. It is advisable to conduct molecular genetic analysis of target genes in IBD patients with very early onset of gastrointestinal lesions, which allows timely diagnosis of congenital defects of the immune system for subsequent prescription of adequate therapy.
- Open Access
- 2 March 2023
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 1,p. 78-85
Analysis of the left ventricular involvement in patients with a biventricular phenotype of arrhythmogenic ardiomyopathy: a case series description
Aim. To assess the prevalence of the left ventricle involvement and the features of the biventricular phenotype of arrhythmogenic cardiomyopathy in patients with pathogenic mutations in the PKP2 and DSP genes.Material and methods. Three unrelated probands underwent a comprehensive molecular-genetic, clinical and instrumental examination, which included a 12-lead ECG, 24-hour ECG monitoring, transthoracic echocardiography, and cardiac magnetic resonance imaging with late gadolinium enhancement.Results. The results of our clinical observations showed that in three studied patients with arrhythmogenic cardiomyopathy left ventricle involvement of various degree was found. The left ventricle damage was characterized by fibrous or fibro-fatty infiltration of the myocardium, as well as regional or global systolic dysfunction of different severity. The patients had pathogenic mutations c.1912C > T (p.Gln638*, rs397517012, rs397517012); c.1237C > T (p.Arg413*, rs372827156) in the PKP2 gene and a new probably pathogenic variant in the form of a c.3494delA deletion in the DSP gene. It was found that the mutation in the DSP gene was associated with a more pronounced systolic dysfunction and a greater percentage of fibrous replacement of the left ventricular myocardium compared with carriers of mutations in the PKP2 gene. All patients had life-threatening ventricular arrhythmias with the need for implantation of a cardioverter-defibrillator.Conclusion. Our clinical observations have shown that in patients with biventricular arrhythmogenic cardiomyopathy, the detection of a mutation in the DSP gene is associated with a more pronounced systolic dysfunction and a higher percentage of fibrous replacement of the left ventricle myocardium compared with carriers of mutations in the PKP2 gene.
- 2 March 2023
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 1,p. 78-85
Open AccessAnalysis of the left ventricular involvement in patients with a biventricular phenotype of arrhythmogenic ardiomyopathy: a case series description
Aim. To assess the prevalence of the left ventricle involvement and the features of the biventricular phenotype of arrhythmogenic cardiomyopathy in patients with pathogenic mutations in the PKP2 and DSP genes.Material and methods. Three unrelated probands underwent a comprehensive molecular-genetic, clinical and instrumental examination, which included a 12-lead ECG, 24-hour ECG monitoring, transthoracic echocardiography, and cardiac magnetic resonance imaging with late gadolinium enhancement.Results. The results of our clinical observations showed that in three studied patients with arrhythmogenic cardiomyopathy left ventricle involvement of various degree was found. The left ventricle damage was characterized by fibrous or fibro-fatty infiltration of the myocardium, as well as regional or global systolic dysfunction of different severity. The patients had pathogenic mutations c.1912C > T (p.Gln638*, rs397517012, rs397517012); c.1237C > T (p.Arg413*, rs372827156) in the PKP2 gene and a new probably pathogenic variant in the form of a c.3494delA deletion in the DSP gene. It was found that the mutation in the DSP gene was associated with a more pronounced systolic dysfunction and a greater percentage of fibrous replacement of the left ventricular myocardium compared with carriers of mutations in the PKP2 gene. All patients had life-threatening ventricular arrhythmias with the need for implantation of a cardioverter-defibrillator.Conclusion. Our clinical observations have shown that in patients with biventricular arrhythmogenic cardiomyopathy, the detection of a mutation in the DSP gene is associated with a more pronounced systolic dysfunction and a higher percentage of fibrous replacement of the left ventricle myocardium compared with carriers of mutations in the PKP2 gene.
- 25 March 2021
- Published by Professionals Publications in Репродуктивное здоровье. Восточная Европа
- No. 1,p. 79-90
Genetic Variation in Genes of Folate Metabolism: Association with Congenital Malformations
Тематика журнала охватывает широкий спектр вопросов профилактики, диагностики и лечения заболеваний в акушерстве, гинекологии, неонатологии, урологии, андрологии, маммологии.
- 25 March 2021
- Published by Professionals Publications in Репродуктивное здоровье. Восточная Европа
- No. 1,p. 79-90
Genetic Variation in Genes of Folate Metabolism: Association with Congenital Malformations
Тематика журнала охватывает широкий спектр вопросов профилактики, диагностики и лечения заболеваний в акушерстве, гинекологии, неонатологии, урологии, андрологии, маммологии.